Skip to content
10-Q

Quarterly Report

Arno Therapeutics, Inc

0001144204-15-065803

← back to feed
Filed
Nov 16, 2015 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2015 · Nov 11, 2015 20.41M sh
Shares Diluted Q3 2015 · Sep 30, 2015 20.41M sh
Shares Diluted Q3 2015 · Sep 30, 2015 20.41M sh
Shares Diluted Q3 2015 · Sep 30, 2014 24.8M sh
Shares Diluted Q3 2015 · Sep 30, 2014 24.8M sh
Capex Q3 2015 · Sep 30, 2015 $0
Capex Q3 2015 · Sep 30, 2014 $20.1K
Stockholders Equity Q3 2015 · Sep 30, 2015 −$5.24M
Stockholders Equity Q3 2015 · Dec 31, 2014 −$588.89K
Current Liabilities Q3 2015 · Sep 30, 2015 $2.16M
Current Liabilities Q3 2015 · Dec 31, 2014 $2.16M
Total Liabilities Q3 2015 · Sep 30, 2015 $5.65M
Total Liabilities Q3 2015 · Dec 31, 2014 $8.84M
Current Assets Q3 2015 · Sep 30, 2015 $374.44K
Current Assets Q3 2015 · Dec 31, 2014 $8.21M
Total Assets Q3 2015 · Sep 30, 2015 $409.81K
Total Assets Q3 2015 · Dec 31, 2014 $8.25M
Eps Diluted Q3 2015 · Sep 30, 2015 −$0.03
Eps Diluted Q3 2015 · Sep 30, 2015 −$0.37
Eps Diluted Q3 2015 · Sep 30, 2014 $0.01
Eps Diluted Q3 2015 · Sep 30, 2014 $0.13
Eps Basic Q3 2015 · Sep 30, 2015 −$0.03
Eps Basic Q3 2015 · Sep 30, 2015 −$0.37
Eps Basic Q3 2015 · Sep 30, 2014 $0.01
Eps Basic Q3 2015 · Sep 30, 2014 $0.16
Cash And Equivalents Q3 2015 · Sep 30, 2014 $11.58M
Cash And Equivalents Q3 2015 · Dec 31, 2013 $26.77M
Sga Expense Q3 2015 · Sep 30, 2014 $1.92M
Sga Expense Q3 2015 · Sep 30, 2014 $5.33M
Rd Expense Q3 2015 · Sep 30, 2014 $3.76M
Rd Expense Q3 2015 · Sep 30, 2014 $12.27M
Net Income Q3 2015 · Sep 30, 2014 $159.44K
Net Income Q3 2015 · Sep 30, 2014 $3.21M
Operating Income Q3 2015 · Sep 30, 2014 −$5.68M
Operating Income Q3 2015 · Sep 30, 2014 −$17.6M